The Molecular Balancing Act of p16INK4a in Cancer and Aging

KM LaPak, CE Burd - Molecular Cancer Research, 2014 - AACR
KM LaPak, CE Burd
Molecular Cancer Research, 2014AACR
Abstract p16INK4a, located on chromosome 9p21. 3, is lost among a cluster of neighboring
tumor suppressor genes. Although it is classically known for its capacity to inhibit cyclin-
dependent kinase (CDK) activity, p16INK4a is not just a one-trick pony. Long-term p16INK4a
expression pushes cells to enter senescence, an irreversible cell-cycle arrest that precludes
the growth of would-be cancer cells but also contributes to cellular aging. Importantly, loss of
p16INK4a is one of the most frequent events in human tumors and allows precancerous …
Abstract
p16INK4a, located on chromosome 9p21.3, is lost among a cluster of neighboring tumor suppressor genes. Although it is classically known for its capacity to inhibit cyclin-dependent kinase (CDK) activity, p16INK4a is not just a one-trick pony. Long-term p16INK4a expression pushes cells to enter senescence, an irreversible cell-cycle arrest that precludes the growth of would-be cancer cells but also contributes to cellular aging. Importantly, loss of p16INK4a is one of the most frequent events in human tumors and allows precancerous lesions to bypass senescence. Therefore, precise regulation of p16INK4a is essential to tissue homeostasis, maintaining a coordinated balance between tumor suppression and aging. This review outlines the molecular pathways critical for proper p16INK4a regulation and emphasizes the indispensable functions of p16INK4a in cancer, aging, and human physiology that make this gene special. Mol Cancer Res; 12(2); 167–83. ©2013 AACR.
AACR